Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study

Fig. 1

Patients with hematologic malignancies who were reported as having COVID-19 and who were included in the present analysis. Reporting hospitals included 22 of the 26 SERMAS regional health service centers (8/8 designated high complexity level hospitals; 10/12 intermediate complexity level; 4/6 low complexity level), and 5 of the 6 private centers

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us